Cargando…

Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy

The standard 12-lead electrocardiogram (ECG) represents a cornerstone for the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM), the most common genetically determined heart muscle disease, due to its cost-effectiveness and wide availability. The ECG may surprisingly look normal in 4–6%...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardini, Andrea, Crotti, Lia, Olivotto, Iacopo, Cecchi, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132576/
https://www.ncbi.nlm.nih.gov/pubmed/37125268
http://dx.doi.org/10.1093/eurheartjsupp/suad074
_version_ 1785031411639517184
author Bernardini, Andrea
Crotti, Lia
Olivotto, Iacopo
Cecchi, Franco
author_facet Bernardini, Andrea
Crotti, Lia
Olivotto, Iacopo
Cecchi, Franco
author_sort Bernardini, Andrea
collection PubMed
description The standard 12-lead electrocardiogram (ECG) represents a cornerstone for the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM), the most common genetically determined heart muscle disease, due to its cost-effectiveness and wide availability. The ECG may surprisingly look normal in 4–6% of adult patients, and in less than 3% of paediatric patients, but it is abnormal in the vast majority of the remaining patients. ‘Specific’ features comprise pathological Q-waves, deep S-waves in V1–V3, or high R-waves in V4–V6 due to left ventricular hypertrophy with T-wave (TW) depression or negative TWs. Negative giant TWs are often found in apical HCM. However, in many patients, the ECG may only show non-specific ST–T changes with diphasic or flat TWs. An isolated inverted TW in lateral leads (usually aVL) may be the only marker for HCM in some patients. Electrocardiogram helps to diagnose sarcomeric HCM and distinguish it from different phenocopies, such as cardiac amyloidosis, glycogen storage, or Fabry disease. Electrocardiogram may also have a prognostic role, identifying high-risk features that could impact the clinical outcome.
format Online
Article
Text
id pubmed-10132576
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-101325762023-04-27 Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy Bernardini, Andrea Crotti, Lia Olivotto, Iacopo Cecchi, Franco Eur Heart J Suppl PLACE 2022 Supplement Paper The standard 12-lead electrocardiogram (ECG) represents a cornerstone for the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM), the most common genetically determined heart muscle disease, due to its cost-effectiveness and wide availability. The ECG may surprisingly look normal in 4–6% of adult patients, and in less than 3% of paediatric patients, but it is abnormal in the vast majority of the remaining patients. ‘Specific’ features comprise pathological Q-waves, deep S-waves in V1–V3, or high R-waves in V4–V6 due to left ventricular hypertrophy with T-wave (TW) depression or negative TWs. Negative giant TWs are often found in apical HCM. However, in many patients, the ECG may only show non-specific ST–T changes with diphasic or flat TWs. An isolated inverted TW in lateral leads (usually aVL) may be the only marker for HCM in some patients. Electrocardiogram helps to diagnose sarcomeric HCM and distinguish it from different phenocopies, such as cardiac amyloidosis, glycogen storage, or Fabry disease. Electrocardiogram may also have a prognostic role, identifying high-risk features that could impact the clinical outcome. Oxford University Press 2023-04-26 /pmc/articles/PMC10132576/ /pubmed/37125268 http://dx.doi.org/10.1093/eurheartjsupp/suad074 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle PLACE 2022 Supplement Paper
Bernardini, Andrea
Crotti, Lia
Olivotto, Iacopo
Cecchi, Franco
Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title_full Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title_fullStr Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title_full_unstemmed Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title_short Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
title_sort diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy
topic PLACE 2022 Supplement Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132576/
https://www.ncbi.nlm.nih.gov/pubmed/37125268
http://dx.doi.org/10.1093/eurheartjsupp/suad074
work_keys_str_mv AT bernardiniandrea diagnosticandprognosticelectrocardiographicfeaturesinpatientswithhypertrophiccardiomyopathy
AT crottilia diagnosticandprognosticelectrocardiographicfeaturesinpatientswithhypertrophiccardiomyopathy
AT olivottoiacopo diagnosticandprognosticelectrocardiographicfeaturesinpatientswithhypertrophiccardiomyopathy
AT cecchifranco diagnosticandprognosticelectrocardiographicfeaturesinpatientswithhypertrophiccardiomyopathy